Aug 2026· Translational Oncology· Vol 72, pp. 102991· 0 citations· 32 references
Medicine
Abstract
Highlights • Cervical carcinoma tissues exhibit elevated expression of STTA and STT3B, with this overexpression significantly correlated with poor patient prognosis.• Knockdown of STT3 markedly impedes the cell cycle in cervical carcinoma cells, inhibiting tumour proliferation while promoting apoptosis.• STT3 regulates epithelial-mesenchymal transition progression via the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 pathways, thereby promoting tumour progression.
Highlights • RSPO1 is upregulated in cervical cancer.• RSPO1 promotes proliferation, migration, invasion, and tumorigenesis in vitro/vivo.• RSPO1 activates EGFR/Src/ERK/AKT axis via LGR4 in cervical cancer.• RSPO1-LGR4 stabilizes EGFR by blocking c-Cbl-mediated ubiquitination/degradation.
Li-Ting Lu, Xi-Duan Wei, Sai Liu et al.· Neoplasia· 0 citations
Highlights • PCK1 is overexpressed in gastric cancer and promotes tumor growth and metastasis.• PCK1 activates the SRC1-JAK1-STAT3 cascade in gastric cancer cells.• The PCK1-SRC1-STAT3 pathway is a potential therapeutic target for gastric cancer.
Jiao Nie, Tian Li, Xing-Yu Yang et al.· Translational Oncology· 0 citations
Highlights • MATR3 is significantly upregulated in colorectal cancer tissues and is associated with poor prognosis in patients.• Knocking out MATR3 significantly inhibits the proliferation, migration, and invasion ability of colorectal cancer cells.• Animal experiments have confirmed that knocking out MATR3 can signifi...
CAV1 is identified as a fibroblast-associated gene linked to stemness- and ferroptosis-related signatures and promoting bladder cancer progression by activating the LIF-STAT3 signaling axis.
Epithelial ovarian cancer (EOC) frequently disseminates within the lipid‐rich peritoneal cavity, where tumor progression is accompanied by metabolic adaptations involving lipid utilization and mitochondrial function. Although these metabolic alterations are increasingly recognized as important features of EOC progressi...
Li-Xue Cao, Yan-Zhen Chen, Ying-Qi Liu et al.· Cancer Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.